Tachosil market report points to faster growth in surgical hemostats

The Business Research Company says the Tachosil market is set to expand through 2026 as surgical volumes rise, trauma cases increase and demand grows for advanced hemostatic patches. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The Tachosil market is tied to rising surgical volumes, trauma care needs and demand for products that help control bleeding and improve tissue sealing. - Growth in minimally invasive surgery and bioactive surgical materials could expand use of patch-based hemostats in operating rooms. - The market outlook matters for hospitals, surgeons and medtech suppliers looking for tools that support faster procedures and fewer complications.

What happened: - The Business Research Company released a 2026 market report on Tachosil, a collagen-based fibrin hemostatic patch used during surgery. - The report says the market is gaining attention as demand for advanced surgical hemostatic solutions increases. - The report highlights market size trends, regional performance, segment details and business strategies. - The report includes a free sample and the full market report.

The details: - Tachosil is designed to control bleeding and support tissue sealing by adhering to tissue surfaces and promoting clotting. - The patch combines a collagen matrix with fibrinogen. - The product is used to support faster healing and reduce complications in surgical procedures. - Historical growth has been driven by more surgical procedures, wider use of collagen-based hemostatic products, and growth in transplant and cardiovascular surgeries. - The report says future demand should benefit from rising investment in advanced wound care, expanding adoption of minimally invasive surgery and a stronger focus on surgical efficiency. - Biodegradable hemostatic technology and patch-based hemostats are listed as key trends for the forecast period. - The report cites Intuitive Surgical, which reported surgical system procedures rising from 2,286,000 in 2023 to 2,683,000 in 2024. - The report also cites Transport Canada, which reported 3,030 fatalities and 233,853 injuries in 173,364 road accidents in 2023, a 4.1% increase in both accidents and injuries. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - Western Europe, Eastern Europe, South America, the Middle East and Africa are also covered in the analysis. - The 2026 report format includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and key technology and future trend analysis.

Between the lines: - The report frames Tachosil as part of a broader shift toward surgical products that reduce blood loss and improve workflow in the operating room. - The focus on trauma and minimally invasive procedures suggests demand may come from both planned surgeries and emergency care. - The regional split points to mature demand in North America and faster adoption potential in markets still expanding healthcare access.

What's next: - The Business Research Company expects growth to continue as hospitals adopt more bioactive and patch-based hemostatic solutions. - Market interest will likely track surgical procedure volumes, healthcare investment and the pace of innovation in wound care and hemostasis. - The report directs readers to the company’s sales and research contacts for more information.